Skip to content

Self-monitoring for women's empowerment to reduce the risks of high blood pressure during life, after a pregnancy with specific high blood pressure

Self-monitoring to empower women to reduce the risk of hypertension later in Life After a Pregnancy with Preeclampsia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6hwx3k
Enrollment
Unknown
Registered
2020-03-09
Start date
2020-03-14
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Interventions

Guidelines for self-monitoring of blood pressure and encouragement to adopt a healthy lifestyle in women who were diagnosed with pre-eclampsia during pregnancy. Intervention group will consist of 60 p
Behavioural

Sponsors

Unesp - universidade estadual paulista
Lead Sponsor
Fapesp - fundação de amparo a pesquisa do estado de São Paulo
Collaborator
Unesp - universidade estadual paulista
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Postpartum patient; age 18 or over; diagnosis of preterm preeclampsia in pregnancy and smartphone and internet access;

Exclusion criteria

Exclusion criteria: Multiple pregnancy; presence of comorbidities, including kidney disease, active liver disease (hepatitis), heart disease, diabetes mellitus and other comorbidities requiring individualized follow-up and women who start a new pregnancy during the study;

Design outcomes

Primary

MeasureTime frame
The primary outcome will be measured by the degree of feasibility and acceptability for conducting a trial comparing home blood pressure self-monitoring with the usual postpartum management of women who had preterm preeclampsia. Thus, the primary outcome will be the number (proportion) of eligible women remaining in the study at each scheduled visit (3, 6, and 12 months postpartum). Viability criterion will be considered whether at least 80% of the randomized population remain in the study up to one year follow-up.

Secondary

MeasureTime frame
It is expected that the patients in the intervention group will self-monitor blood pressure according to the guidelines and that at least 80% of these will remain in the study within one year;It is believed that patients' anxiety during follow-up has a positive impact and is lessened in relation to the control group. This assessment will be carried out using a pre-established questionnaire about the state of anxiety;It is expected that adherence to the use of medications, when indicated, will be greater in the group that receives counseling than in the control group, this measurement will be obtained through clinical evaluation of patients on their outpatient returns.;It is believed that there will be improvements in the quality of life and development of healthy lifestyle more markedly in the intervention group, this evaluation will be carried out through questionnaires directed to these parameters and that will be applied in the outpatient return visits

Countries

Brazil

Contacts

Public ContactWilson Minoru Koike

Unesp - universidade estadual paulista

wilkoike@gmail.com+55-14-997171921

Outcome results

None listed

Source: REBEC (via WHO ICTRP)